Facultad de Ciencias de la Salud
Facultad
Hospital Universitario La Paz
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario La Paz (52)
2024
-
Incidence of T2DM and the role of baseline glycaemic status as a determinant in a metropolitan population in northern Madrid (Spain)
Diabetes Research and Clinical Practice, Vol. 209
2023
-
Cardiac System during the Aging Process
Aging and Disease, Vol. 14, Núm. 4, pp. 1105-1122
-
Identifying the patient with heart failure to be treated with vericiguat
Current Medical Research and Opinion, Vol. 39, Núm. 5, pp. 661-669
-
Optimizing the management of patients with worsening heart failure: beyond heart failure hospitalization
Expert Opinion on Pharmacotherapy, Vol. 24, Núm. 6, pp. 705-713
-
The Impact of Colistin Resistance on the Activation of Innate Immunity by Lipopolysaccharide Modification
Infection and immunity, Vol. 91, Núm. 2, pp. e0001223
-
Thiosulfinate-Enriched Allium sativum Extract Exhibits Differential Effects between Healthy and Sepsis Patients: The Implication of HIF-1α
International journal of molecular sciences, Vol. 24, Núm. 7
2022
-
Factors associated with mortality due to SARS-CoV-2 in the population over 75 years of age in the Community of Madrid
Revista Clinica Espanola, Vol. 222, Núm. 8, pp. 468-478
-
Glycemic variability and all-cause mortality in a large prospective southern European cohort of patients with differences in glycemic status
PLoS ONE, Vol. 17, Núm. 7 July
-
Impact of blood pressure on management and prognosis of patients treated with sacubitril/valsartan
REC: CardioClinics, Vol. 57, Núm. 2, pp. 116-122
-
Individualizing the treatment of patients with heart failure with reduced ejection fraction: a journey from hospitalization to long-term outpatient care
Expert Opinion on Pharmacotherapy, Vol. 23, Núm. 14, pp. 1589-1599
2021
-
Description of the genetic variants identified in a cohort of patients diagnosed with localized anal squamous cell carcinoma and treated with panitumumab
Scientific Reports, Vol. 11, Núm. 1
-
Effect of depression on mortality in type 2 diabetes mellitus after 8 years of follow-up. The DIADEMA study
Diabetes Research and Clinical Practice, Vol. 176
-
Effectiveness and safety of a single-dose ivermectin treatment for uncomplicated strongyloidiasis in immunosuppressed patients (Immunostrong study): The study protocol
Pathogens, Vol. 10, Núm. 7
-
Immune expression profile identification in a group of proliferative verrucous leukoplakia patients: a pre-cancer niche for oral squamous cell carcinoma development
Clinical Oral Investigations, Vol. 25, Núm. 5, pp. 2645-2657
-
Initiation and titration of sacubitril/valsartan in different types of centers
REC: CardioClinics, Vol. 56, Núm. 2, pp. 92-97
-
Physiopathology, diagnosis, and management of hypomagnesemia in heart failure patients
REC: CardioClinics
-
SARS-CoV-2 IgG seropositivity in a cohort of 449 non-hospitalized individuals during Spanish COVID-19 lockdown
Scientific Reports, Vol. 11, Núm. 1
2020
-
Genomics of Serratia marcescens Isolates Causing Outbreaks in the Same Pediatric Unit 47 Years Apart: Position in an Updated Phylogeny of the Species
Frontiers in Microbiology, Vol. 11
-
Left Ventricular Ejection Fraction Recovery in Patients with Heart Failure and Reduced Ejection Fraction Treated with Sacubitril/Valsartan
Cardiology (Switzerland), Vol. 145, Núm. 5, pp. 275-282
-
Sacubitril/Valsartan is useful and safe in elderly people with heart failure and reduced ejection fraction. Data from a real-word cohort
Revista Espanola de Geriatria y Gerontologia, Vol. 55, Núm. 2, pp. 65-69